Useful Tools for the Management of Atopic Dermatitis

被引:34
作者
Ricci, Giampaolo [1 ]
Dondi, Arianna [1 ]
Patrizi, Annalisa [2 ]
机构
[1] Univ Bologna, Dept Pediat, I-40138 Bologna, Italy
[2] Univ Bologna, Dept Clin & Expt Med, Div Dermatol, I-40138 Bologna, Italy
关键词
TOPICAL CALCINEURIN INHIBITORS; HOUSE-DUST MITE; QUALITY-OF-LIFE; NATURAL COURSE; FOOD ALLERGY; REVISED NOMENCLATURE; INITIAL VALIDATION; ECZEMA SEVERITY; CREAM; 1-PERCENT; SCORAD INDEX;
D O I
10.2165/11310760-000000000-00000
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Eczema, frequently named atopic dermatitis, is the most frequent chronic skin disease of early childhood, with a high prevalence in industrialized countries and a relapsing-remitting course that is responsible for a serious burden on affected children and their families. Even though most facets of this disease are nowadays well known and numerous guidelines are available, some confusion still exists regarding certain aspects. First, several names have been proposed for the disorder. We suggest that the name and definition adopted by the World Allergy Organization should be used: 'eczema,' divided into 'atopic,' when an allergic sensitization can be demonstrated, and 'non-atopic,' in the absence of sensitization. Several diagnostic criteria have been proposed, but at present the two most reliable are the 2003 revision by the American Academy of Dermatology of the Hanifin-Rajka criteria, and those by Williams revised in 2005. To date, 20 different clinical scores have been published to assess the severity; however, only the EASI (Eczema Area and Severity Index), the SCORAD (SCORing Atopic Dermatitis), and the POEM (Patient-Oriented Eczema Measure) seem to have been adequately validated and are recommended for use in clinical practice and trials. The diagnostic tests to identify associated allergy or sensitization include skin-prick tests, determination of the specific IgE in serum using different assays, and atopy patch tests; in the case of suspected food allergy, a food challenge may be necessary to define the diagnosis. To evaluate quality of life, tools exist that allow both the child's and family's impairment to be considered. In addition, several algorithms exist to help decide therapy on a step-wise basis. However, such guidelines and algorithms represent only an aid to the physician and not an obligatory directive, since the ultimate judgment regarding any therapy must be performed by the physician and tailored to individual needs. A clear and validated definition of eczema control would permit better monitoring of the disease, similar to the situation with asthma in recent years. Finally, the review examines the role of special textiles in diminishing Staphylococcus aureus skin superinfection, of house dust-mite avoidance measures, and of educational programs for patients and their families, which may all help improve eczema.
引用
收藏
页码:287 / 300
页数:14
相关论文
共 99 条
[1]  
Abramovits W, 2005, J AM ACAD DERMATOL, V53, pS70, DOI 10.1016/j.jaad.2005.04.032
[2]   Changing paradigms in dermatology: Topical immunomodulators within a permutational paradigm for the treatment of atopic and eczematous dermatitis [J].
Abramovits, W ;
Goldstein, AM ;
Stevenson, LC .
CLINICS IN DERMATOLOGY, 2003, 21 (05) :383-391
[3]   Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report [J].
Akdis, C. A. ;
Akdis, M. ;
Bieber, T. ;
Bindslev-Jensen, C. ;
Boguniewicz, M. ;
Eigenmann, P. ;
Hamid, Q. ;
Kapp, A. ;
Leung, D. Y. M. ;
Lipozencic, J. ;
Luger, T. A. ;
Muraro, A. ;
Novak, N. ;
Platts-Mills, T. A. E. ;
Rosenwasser, L. ;
Scheynius, A. ;
Simons, F. E. R. ;
Spergel, J. ;
Turjanmaa, K. ;
Wahn, U. ;
Weidinger, S. ;
Werfel, T. ;
Zuberbier, T. .
ALLERGY, 2006, 61 (08) :969-987
[4]  
[Anonymous], 1995, Global Strategy for Asthma Management and Prevention
[5]   Topical pimecrolimus for eczema [J].
Ashcroft, D. M. ;
L-C, Chen ;
Garside, R. ;
Stein, K. ;
Williams, H. C. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (04)
[6]   Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood:: ISAAC Phases One and Three repeat multicountry cross-sectional surveys [J].
Asher, M. Innes ;
Montefort, Stephen ;
Bjorksten, Bengt ;
Lai, Christopher K. W. ;
Strachan, David P. ;
Weiland, Stephan K. ;
Williams, Hywel .
LANCET, 2006, 368 (9537) :733-743
[7]   Dietary exclusions for established atopic eczema [J].
Bath-Hextall, F. ;
Delamere, F. M. ;
Williams, H. C. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01)
[8]   ITCHING FROM WOOL FIBERS IN ATOPIC-DERMATITIS [J].
BENDSOE, N ;
BJORNBERG, A ;
ASNES, H .
CONTACT DERMATITIS, 1987, 17 (01) :21-22
[9]   The use of topical calcineurin inhibitors in dermatology: Safety concerns - Report of the American Academy of Dermatology Association Task Force [J].
Berger, TG ;
Duvic, M ;
Van Voorhees, AS ;
Frieden, IJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (05) :818-823